{"id":3910,"date":"2018-10-23T09:34:14","date_gmt":"2018-10-23T07:34:14","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/23102018_Enterome-PR-EB8018-Takeda-FR-Final.pdf"},"modified":"2018-10-23T09:34:14","modified_gmt":"2018-10-23T07:34:14","slug":"23102018_enterome-pr-eb8018-takeda-fr-final-2","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/enterome-signs-global-licensing-co-development-and-co-promotion-agreement-with-takeda-for-the-treatment-of-crohns-disease\/23102018_enterome-pr-eb8018-takeda-fr-final-2\/","title":{"rendered":"23102018_Enterome-PR-EB8018-Takeda-FR-Final"},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-3910","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n